Back to dashboard
Low impact

Chimeric Antigen Receptor (CAR) T-cell Therapy - Medicare Advantage (Revised)

Humana·Medicare Advantage
Effective date
Not stated
We identified it
Jul 30, 2026
Days to comply
—

Related policy hubs

Chimeric Antigen Receptor (CAR) T-cell Therapy - Medicare Advantage (Revised) | Humana | PolicyChanges.app